apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Rez-Q 300 Injection 2 ml
  3. Rez-Q 300 Injection 2 ml Substitute

Rez-Q 300 Injection 2 ml Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

QUININE-300MG

Uses:

Malaria

Medicinal Benefits:

Rez-Q 300 Injection 2 ml belongs to the class of 'anti-malarial drugs,' containing Quinine, primarily used to treat malaria. It treats malaria by increasing the levels of hemozoin (a toxic substance to the malarial parasite) in the blood. As a result, it kills the parasite and helps to stop the infection from spreading further.

FAQs

Rez-Q 300 Injection 2 ml belongs to the class of 'anti-malarial drugs', containing Quinine that treats malaria by increasing the levels of hemozoin (a toxic substance to the malarial parasite) in the blood. As a result, it kills the parasite and helps to stop the infection from spreading further.

You should not take Rez-Q 300 Injection 2 ml if you have or ever had a heart rhythm disorder called Long QT syndrome, glucose-6-phosphate dehydrogenase deficiency (G-6-PD), myasthenia gravis (a muscle disorder), optic neuritis (inflammation of the nerves in your eyes) if taking Rez-Q 300 Injection 2 ml in the past ever caused bleeding.

Rez-Q 300 Injection 2 ml can cause a lowering of blood sugar levels. So, if you are diabetic, please inform your doctor before starting treatment with Rez-Q 300 Injection 2 ml, and dose adjustment might be required depending upon your medical condition.

Rez-Q 300 Injection 2 ml may affect the heart rhythm and cause QT prolongation (heart muscle takes longer than usual to recharge between beats). This QT prolongation can cause a serious fast/irregular heartbeat. Hence it is advised to inform your doctor if you have any heart-related problems like heart failure, slow heartbeat, QT prolongation in EKG or ECG (electrocardiogram) and a family history of heart diseases.

Glucose-6-phosphate dehydrogenase deficiency is a hereditary condition that affects red blood cells. A defect in an enzyme called glucose-6-phosphate dehydrogenase in affected individuals causes red blood cells to break down prematurely. It leads to hemolytic anaemia, which happens when red blood cells are destroyed faster than the body can replenish them.